Collectively, these results demonstrate that NRG1 is expressed by CAFs in the stroma of luminal breast cancer patients and reinforce the concept of a paracrine-driven activation of HER3 in the luminal breast cancer subtype. This evidence concerns the gene ERBB3 and breast cancer.